Molecular structure of human histocompatibility antigens: the HLA‐C series
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The HLA‐CW2 antigen of the B lymphoblastoid cell line BRI 8 is structurally homologous to the HLA‐A and B antigens as judged by various criteria. Each antigen comprised a glycosylated polypeptide of 43 000 molecular weight that is noncovalently associated with β 2–microglobulin (β 2 m). Some small differences in molecular parameters were, however, revealed. Thus, the deoxycholate‐solubilized HLA‐CW2 antigen sedimented at the same rate as the HLA‐A antigens but at a slightly faster rate than the HLA‐B antigens. This variation is apparently due to different amounts of bound deoxy‐cholate. Also, whereas essentially all of the HLA‐A and B antigens and about half of the HLA‐CW2 antigen were adsorbed Strongly by Lens culinaris lectin‐Sepharose, the remaining HLA‐CW2 antigen was bound much more weakly and did not require sugar for elution. This difference reflects some structural heterogeneity in the carbohydrate moiety of the HLA‐CW2 antigen. The results of various studies suggest that the HLA‐CW2 antigen is expressed to a lower extent than the HLA‐A or B antigens and that essentially all of the β 2 m of the BRI 8 plasma membrane is associated with the HLA‐A, B and C alloantigenic polypeptides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings may be explained because HLA-B is generally expressed at higher levels on the cell surface than HLA-A and HLA-C and because HLA-B alleles bind to a greater diversity of peptides (38, 39).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [38]
Citations
Cites
Braun, W. E., Grecek, D. R., & Murphy, J. J. (1971) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)39542-1 · Cited by 1,897
HISTOCOMPATIBILITY TESTING, 1972
(1974) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb70792.x · Cited by 1,178
Histocompatibility Testing, 1975
Taylor, G. M. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.129 · Cited by 778
Hayman, M. J., & Crumpton, M. J. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90581-5 · Cited by 346
Self-citationThe β2-microglobulin gene is on chromosome 15 and not in the HL-A region
GOODFELLOW, P. N., JONES, E. A., VAN HEYNINGEN, V., SOLOMON, E., BOBROW, M., MIGGIANO, V., & BODMER, W. F. (1975) · Nature · doi:10.1038/254267a0 · Cited by 272
Self-citationEffect of dimethylnitrosamine on persistence of methylated guanines in rat liver and kidney DNA
NICOLL, J. W., SWANN, P. F., & PEGG, A. E. (1975) · Nature · doi:10.1038/254261a0 · Cited by 184
Chemical characterisation of the Thy-1 glycoproteins from the membranes of rat thymocytes and brain
Neil Barclay, A., Letarte-Muirhead, M., Williams, A. F., & Faulkes, R. A. (1976) · Nature · doi:10.1038/263563a0 · Cited by 182
EXPRESSION OF HLA SYSTEM ANTIGENS ON PLACENTA
Goodfellow, P. N., Barnstable, C. J., Bodmer, W. F., Snary, D., & Crumpton, M. J. (1976) · Transplantation · doi:10.1097/00007890-197612000-00009 · Cited by 180
Self-citationPapain-Solubilized HL-A Antigens from Cultured Human Lymphocytes Contain Two Peptide Fragments
Cresswell, P., Turner, M. J., & Strominger, J. L. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.5.1603 · Cited by 164
Terhorst, C., Parham, P., Mann, D. L., & Strominger, J. L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.910 · Cited by 162
Research works printed but not linked: 9
- Möller G., 1974, Transplant. Rev., 21
- Tanigaki N., 1974, Immunology, 26, 155
- Arce‐Gomez B. Jones E.A. Barnstable C.J. Solomon E.andBodmer W.F. Tissue Antigens1977 in press.
- Mayr W.R., 1973, Transplant. Proc., 5, 1581
- Dausset J., 1973, Histocompatibility Testing 1972
- Bodmer W.F., 1973, Manual of Tissue Typing Techniques, 74
- Nakamuro K., 1977, Immunology, 32, 139
- Snary D., 1977, Proc Cell Culture Conf., and Birmingham, A.a.
- Bodmer W.F., 1973, Transplant Proc., 5, 1471
Cited by
Items 101–181 of 181
Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses
Goulder, P., Bunce, M., Luzzi, G. A., Phillips, R. E., & McMichael, A. (1997) · AIDS · doi:10.1097/00002030-199715000-00016 · Cited by 22
Biomarkers for predicting the outcome of various cancer immunotherapies
Jafarzadeh, L., Khakpoor-Koosheh, M., Mirzaei, H., & Mirzaei, H. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103161 · Cited by 22
HLA-G/C, miRNAs, and Their Role in HIV Infection and Replication
Celsi, F., Catamo, E., Kleiner, G., Tricarico, P. M., Vuch, J., & Crovella, S. (2013) · BioMed Research International · doi:10.1155/2013/693643 · Cited by 21
“HLA-C can present antigens to CTL, and it is able to inhibit NK cell lysis, but for some reason it is normally expressed on the cell surface at levels approximately 10-fold less than most HLA-A and HLA-B allotypes [60].”
BackgroundThere is more to HLA‐C than exons 2 and 3: sequencing of exons 1, 4 and 5
Vlies, S. A. V. D., Voorter, C. E. M., & van den Berg-Loonen, E. M. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540208.x · Cited by 21
Trägårdh, L., Wiman, K. G., Rask, L., & Peterson, P. A. (1979) · Biochemistry · doi:10.1021/bi00574a031 · Cited by 21
Torimiro, J. N. E., Carr, J. K., WOLFE, N. D., Karacki, P., Martin, M. P., Gao, X., Tamoufé, U., Thomas, A., Ngole, E. M., Birx, D. L., et al. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00527.x · Cited by 20
HIV and host immunogenetics: unraveling the role of HLA ‐C
Bardeskar, N. S., & Mania‐Pramanik, J. (2016) · HLA · doi:10.1111/tan.12882 · Cited by 24
“HLA-C is generally expressed in lower levels as compared with HLA-A and HLA-B; sometimes even up to a level 10-fold lower (30).”
BackgroundTakács, B. (1980) · Molecular Immunology · doi:10.1016/0161-5890(80)90026-7 · Cited by 20
Structural characterization of antigens encoded by rabbitRLA-11 histocompatibility genes
Kimball, E. S., Coligan, J. E., & Kindt, T. J. (1979) · Immunogenetics · doi:10.1007/bf01561430 · Cited by 20
Isolation and characterization of a genomic HLA‐Cw6 clone
Steinle, A., NiEner, E., & Schendel, D. J. (1992) · Tissue Antigens · doi:10.1111/j.1399-0039.1992.tb01923.x · Cited by 20
Chikata, T., Paes, W., Akahoshi, T., Partridge, T., Murakoshi, H., Gatanaga, H., Ternette, N., Oka, S., Borrow, P., & Takiguchi, M. (2019) · Journal of Virology · doi:10.1128/jvi.00634-19 · Cited by 22
“Although further studies with additional HLA-A, HLA-B, and HLA-C alleles will be required to enable robust conclusions to be drawn about differences in the efficiency with which epitopes presented by HLA-A/B and HLA-C alleles induce CD8 T cell priming in HIV-infected individuals, it is tempting to speculate that the l…”
Studies on Biosynthesis, Assembly and Expression of Human Major Transplantation Antigens
Algranati, I. D., Milstein, C., & ZIEGLER, A. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04304.x · Cited by 19
Lü, Z., Chen, H., Jiao, X., Wang, Y., Wu, L., Sun, H., Li, S., Gong, J., Li, J., Zou, J., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00997-6 · Cited by 22
Immunochemical ANALYSIS OF GLYCOSYLATED AND nonglycosylated dla class I antigens
van der Feltz, M. J. M., & Ploegh, H. L. (1984) · Immunogenetics · doi:10.1007/bf00387852 · Cited by 17
In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
Tong, J. C., Zhang, Z. H., August, J. T., Brusić, V., Tan, T. W., & Ranganathan, S. (2007) · Immunome Research · doi:10.1186/1745-7580-3-7 · Cited by 16
“Although several HLA-C specificities with CTL epitopes have been reported [1,2], much remains unknown with regards to their role in the immune response against viral antigens in part due to their poor expression at the cell surface [3,4].”
BackgroundIsolation and Properties of Detergent‐Solubilized HLA Antigens Obtained from Platelets
Trägårdh, L., Klareskog, L., Curman, B., Rask, L., & Peterson, P. A. (1979) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1979.tb03168.x · Cited by 16
Walshe, V. A., Hattotuwagama, C. K., Doytchinova, I. A., Wong, M., Macdonald, I. K., Mulder, A., Claas, F. H. J., Pellegrino, P., Turner, J., Williams, I. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008095 · Cited by 15
“This is likely due to the fact that they are expressed at lower levels on the cell surface than HLA-A and -B alleles [20], and a higher proportion of CD8+ T cell responses are believed to be restricted by HLA-B and HLA-A, with HLA-C a poor third [21,22].”
BackgroundBERNOCO, D., Byrns, G., Bailey, E., & Lew, A. M. (1987) · Animal Genetics · doi:10.1111/j.1365-2052.1987.tb00749.x · Cited by 15
Cereb, N., Choi, J. W., Lee, S., Maye, P. F., Kong, Y., & Yang, S. Y. (1994) · Tissue Antigens · doi:10.1111/j.1399-0039.1994.tb02379.x · Cited by 15
Interallelic recombination has not played a major role in the history of the HLA-C locus
Yeager, M., & Hughes, A. (1996) · Immunogenetics · doi:10.1007/bf02660061 · Cited by 15
HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces
Kennedy, P. R., Barthen, C., Williamson, D. J., & Davis, D. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00061 · Cited by 14
Antigen Processing, Presentation, and Tolerance: Role in Autoimmune Skin Diseases
Prinz, J. C. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.009 · Cited by 13
Hajek-Rosenmayr, A., Jungl, L., Stammler, M., & Kirnbauer, M. (1989) · Human Immunology · doi:10.1016/0198-8859(89)90001-3 · Cited by 13
On stand by: host genetics of HIV control
Carrington, M. N., Bashirova, A. A., & McLaren, P. J. (2013) · AIDS · doi:10.1097/01.aids.0000432536.85335.c8 · Cited by 11
“the cell surface [22,23], and more extensive ligandreceptor interactions with killer cell immunoglobulinlike receptor (KIR) [24].”
BackgroundDepierreux, D., Altenburg, A. F., Soday, L., Fletcher-Etherington, A., Antrobus, R., Ferguson, B. J., Weekes, M. P., & Smith, G. L. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010612 · Cited by 10
“Therefore, only peptides corresponding uniquely to a single HLA-I type were included in this analysis.”
BackgroundInfluentialAnand, S., Littler, D. R., Mobbs, J. I., Braun, A., Baker, D. G., Tennant, L., Purcell, A. W., Vivian, J. P., & Rossjohn, J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104930 · Cited by 10
“The healthy and diseased peptide repertoires presented by human HLA-A and HLA-B allomorphs have historically been preferentially studied due to their higher abundance (16, 17).”
BackgroundExpression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule
Layet, C., Delovitch, T. L., Ferrier, P., Caillol, D. H., Jordan, B., & Lemonnier, F. A. (1985) · Immunogenetics · doi:10.1007/bf00430930 · Cited by 10
“However, a precise analysis of the serological reactivities associated with the products of the C locus was previously difficult to perform because of the limited amount of these products at the surface of human cells (Snary et al. 1977) and their simultaneous expression with the HLA-A and -B class I molecules.”
BackgroundHistocompatibility considerations for kidney paired donor exchange programs
Murphey, C. L., & Bingaman, A. W. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283556ff2 · Cited by 9
“For example, it is well established that C locus antigens are expressed at low levels compared with A and B locus class I antigens [23,24].”
BackgroundInefficient assembly limits transport and cell surface expression of HLA‐Cw4 molecules in C1R
Zemmour, J. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02688.x · Cited by 9
Non-major histocompatibility complex alloantigen genes affecting immunity
Briles, W. E. (2004) · Poultry Science · doi:10.1093/ps/83.4.606 · Cited by 8
Chikata, T., Paes, W., Kuse, N., Partridge, T., Gatanaga, H., Zhang, Y., Kuroki, K., Maenaka, K., Ternette, N., Oka, S., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00432-22 · Cited by 8
The HLA Likes and Dislikes of Allospecific and Non‐MHC‐Restricted Cytotoxic T Lymphocytes
Nößner, E., Falk, C. S., Jantzer, P., Reinhardt, C., Steinle, A., & Schendel, D. J. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00931.x · Cited by 8
“Since HLA-C molecules are expressed at substantially lower levels than HLA-A and -B (Snary et al. 1977), shght differences in expression may alter the inhibitory signal in the effector cells that provides protection from lysis for normal cells.”
BackgroundLoon, J., Terasaki, P. I., & BERNOCO, D. (1981) · Tissue Antigens · doi:10.1111/j.1399-0039.1981.tb01403.x · Cited by 8
[52] Purification of human HLA-A and HLA-B class I histocompatibility antigens
de Castro, J. L. (1984) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(84)08119-2 · Cited by 8
Kuse, N., Akahoshi, T., & Takiguchi, M. (2021) · Journal of Virology · doi:10.1128/jvi.00699-21 · Cited by 7
Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens
Hesnard, L., Thériault, C., Cahuzac, M., Durette, C., Vincent, K., Hardy, M., Lanoix, J., Lavallée, G. O., Humeau, J., Thibault, P., et al. (2024) · Current Oncology · doi:10.3390/curroncol31060236 · Cited by 6
“B allotypes since HLA-C molecules are expressed at lower levels at the cell surface [40].”
BackgroundStoll, A., Bergmann, S., Mummert, C., Mueller-Schmucker, S. M., Spriewald, B. M., Harrer, E. G., & Harrer, T. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.01.005 · Cited by 6
Nicuesa, L. H., Hernández-Flórez, D., Valor, L., García-Consuegra, S., Navarro-Valdivieso, J. P., Fernández‐Cruz, E., & Rodríguez-Sáinz, C. (2017) · Journal of Immunology Research · doi:10.1155/2017/8689313 · Cited by 6
Zhang, Y., Murakoshi, H., Chikata, T., Akahoshi, T., Tran, G. V., Trung, N. V., Gatanaga, H., Nguyen, K. V., Oka, S., Kuse, N., et al. (2020) · Journal of Virology · doi:10.1128/jvi.02061-20 · Cited by 6
Influence of Disease Severity and Gender on HLA-C Methylation in COVID-19 Patients
Sharif-zak, M., Abbasi-Jorjandi, M., Asadikaram, G., Ghoreshi, Z., Rezazadeh-Jabalbarzi, M., & Rashidinejad, H. (2022) · Iranian Journal of Science and Technology Transactions A Science · doi:10.1007/s40995-022-01334-1 · Cited by 6
“Also, previous studies described that HLA-C is a hetero-trimer with a high polymorphism rate, with approximately 5,600 alleles that could be different in various persons (Snary et al. 1977; Zemmour and Parham 1992).”
BackgroundMolinari, A., Formisano, G., & Malorni, W. (1987) · Cell Biology and Toxicology · doi:10.1007/bf00119914 · Cited by 6
Studies on binding of HIV-1 p24gag peptide to HLA-Cw3+ cells
Kość, A., Dubis, J., Wojciechowska, I., Maćkiewicz, Z., Gorczyca, W., Myc, A., Kupryszewski, G., Mańczak, M., Myc, P. P., & Kuśnierczyk, P. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00079-0 · Cited by 6
Lisovsky, I., Isitman, G., Tremblay-McLean, A., Song, R., DaFonseca, S., Lebouché, B., Jp, R., Bruneau, J., & Bernard, N. F. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12849 · Cited by 5
The Effect of HLA Polymorphisms on the Recognition of Gag Epitopes in HIV-1 CRF01_AE Infection
Sriwanthana, B., Mori, M., Tanaka, M., Nishimura, S., Miura, T., Pathipvanich, P., Sawanpanyalert, P., & Ariyoshi, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041696 · Cited by 4
“The lower level of cell surface expression of HLA-C alleles compared to the other alleles [39–41] and the lack of protective HLA-C allele information in population studies [10– 12] has hampered epitope mapping against HLA-C alleles.”
ResultAltenburg, A. F., Morley, J. L., Decatris, S. M., Bauer, J., Walz, J. S., & Boyle, L. H. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.20738.2 · Cited by 4
“B 46 , further complicating detection of interactions.”
Murakoshi, H., Chikata, T., Akahoshi, T., Zou, C., Borghan, M. A., Tran, G. V., Trung, N. V., Nguyen, K. V., Kuse, N., & Takiguchi, M. (2020) · AIDS · doi:10.1097/qad.0000000000002704 · Cited by 4
“One substitution lower than that of HLA-A or HLA-B ones [39,40].”
Immunology of Leucocytes, Platelets and Plasma Components
Klein, H. G., & FMedSci, D. J. A. P. F. (2005) · Wiley eBooks · doi:10.1002/9780470986868.ch13 · Cited by 4
Jin, Y., Wei, P., Niu, B.-X., Li, M., & Yang, Q. (2013) · Food and Agricultural Immunology · doi:10.1080/09540105.2013.768963 · Cited by 4
The HLA‐C *03:539 allele identified in a kidney transplantation recipient
Yang, J. J., Kwon, O. ‐., & Oh, H. (2020) · HLA · doi:10.1111/tan.14121 · Cited by 3
“However, mismatch of the HLA-C locus antigens are often disregarded in organ sharing protocols due to its lower extent of expression and low antigenicity compared to HLA-A or -B antigens.(2,3) Here, we report a novel HLA-C allele, now named HLA-C*03:539, discovered during retransplantation workup of a previous living-…”
BackgroundThe novel HLA‐C*06:325 allele identified in a Korean individual awaiting kidney transplantation
Yang, J. J., Kwon, O. ‐., & Oh, H. (2022) · HLA · doi:10.1111/tan.14618 · Cited by 3
Arakawa, Y., Arakawa, A., Vural, S., He, M. L., Vollmer, S., & Prinz, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072858 · Cited by 3
“Compared to the overall HLA-class I expression (HLA-ABC), the baseline level of HLA-C on the cell surface was low, as described [46].”
Bardeskar, N. S., Chavan, V. R., Ahir, S., Nanavati, R. N., Samant‐Mavani, P., Mehta, P., & Mania‐Pramanik, J. (2018) · Immunogenetics · doi:10.1007/s00251-018-1075-1 · Cited by 3
Suzuki, H., Joshita, S., Hirayama, A., Shinji, A., Mukawa, K., Sako, M., Yoshimura, N., Suga, T., Umemura, T., Ashihara, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69370-8 · Cited by 3
On the nature of “HLA‐B41+B42” alloantibodies. Specific reagents for HLA‐Cw*17?
Herrero, M. J., Bunce, M., van Dam, M., de Pablo, R., & Vilches, C. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03031.x · Cited by 3
Are the Classic Transplantation Antigens Primitive Cell-Surface Antibodies?
Peterson, P. A., & Kämpe, O. (1981) · Springer eBooks · doi:10.1007/978-1-4684-3758-4_18 · Cited by 3
Genomic Confirmation of HLA‐C*14:84 , by Next Generation Sequencing
Merschman, J., Benidt, D., Kreuter, J. D., Barnes, R., & Gandhi, M. J. (2026) · HLA · doi:10.1111/tan.70733 · Cited by 2
Genomic Confirmation of HLA‐C*12:68 by Next Generation Sequencing
Merschman, J., Kreuter, J. D., Schneider, B. A., & Gandhi, M. J. (2026) · HLA · doi:10.1111/tan.70740 · Cited by 2
“B, which correlates with restricted peptide binding and stronger association with TAP during peptide loading [1, 2].”
Silva, M., Osório, N. S., & Saraiva, M. (2025) · Microorganisms · doi:10.3390/microorganisms13051032 · Cited by 2
“We excluded HLA-C class I alleles due to their limited polymorphism and lower expression levels (about 90% less) compared to the other two loci [55–57].”
Malnati, M., Biswas, P., Ugolotti, E., Marco, E. D., Sironi, F. M., Parolini, F., Garbarino, L., Mazzocco, M., Zipeto, D., & Biassoni, R. (2020) · HLA · doi:10.1111/tan.13971 · Cited by 2
Immunology of Leucocytes, Platelets and Plasma Components
Klein, H. G., & Anstee, F. D. J. (2013) · Wiley eBooks · doi:10.1002/9781118689943.ch13 · Cited by 2
Antisera Recognising HLA‐A, ‐B and DRW Antigens Raised in Rhesus Monkeys
Barnstable, C. J., Snary, D., Crumpton, M. J., BALNER, H., & Bodmer, W. F. (1980) · Tissue Antigens · doi:10.1111/j.1399-0039.1980.tb00203.x · Cited by 2
Self-citationMoore, S. B. (1979) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)19078-2 · Cited by 4
Jo, H.-A., Hyun, S., Hyun, Y., Lee, Y., Kim, S.-M., Baek, I., Sohn, H., & Kim, T. (2023) · Immune Network · doi:10.4110/in.2023.23.e17 · Cited by 1
“The sum of CD8+ T cell responses in all HLA class I allotypes had a mean of 98.2 SFCs/5×105 CD8+ T cells, and HLA-A, HLA-B, and HLA-C had means of 41.8, 30, and 26.4 SFCs, respectively.”
BackgroundInfluentialHLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection
Olp, M. D., Laufer, V. A., Valesano, A. L., Zimmerman, A. A., Woodside, K. J., Lu, Y., Lauring, A. S., & Cusick, M. F. (2024) · Life · doi:10.3390/life14091181 · Cited by 1
“HLA-C molecules are expressed in lower quantities at the cell surface [68–71], compared with HLA-A and -”
BackgroundNöBner, E., & Schendel, D. J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb01867.x · Cited by 1
Head and neck squamous cell carcinoma susceptibility genes in the HLA region
Reinders, J. (2006) · Utrecht University Repository (Utrecht University)
The T cell repertoire specific for the IE-1 protein of human cytomegalovirus
Ameres, S. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16717
Characterization of antigens of the dog major histocompatibility complex
van der Feltz, M. (1983)
Fu, L. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3x63bg8q
A Novel System to Discriminate HLA-C mir148a Binding Site by Allele-Specific Quantitative PC R
Biswas, P., Marco, E. D., & Malnati, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9833-3_5
Measuring HLA-B allele expression across differential cell types.
Ramphal, U. (2018) · ResearchSpace (University of KwaZulu-Natal)
Bouteiller, P. P. L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737094913.793571609
Münz, C., & Chijioke, O. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735084294.793557461
Lü, Z., Chen, H., Jiao, X., Wang, Y., Wu, L., Sun, H., Li, S., Gong, J., Li, J., Zou, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16928613
Kuse, N., Noyori, O., Takahashi, N., Zhang, Y., Suzu, S., & Takiguchi, M. (2024) · Journal of Virology · doi:10.1128/jvi.00791-24
“HLA-A-restricted or HLA-B-restricted CD8 + T cells have an important role in var ious viral infections compared with HLA-C-restricted CD8 + T cells because the sur face expression levels of HLA-A and HLA-B are much higher than that of HLA-C (40–42).”
BackgroundInfluentialLu, Z., Chen, H., Jiao, X., Wang, Y., Wu, L., Sun, H., Li, S., Gong, J., Li, J., Zou, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16928616
Lu, Z., Chen, H., Jiao, X., Wang, Y., Wu, L., Sun, H., Li, S., Gong, J., Li, J., Zou, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16928619
Chikata, T., Akahoshi, T., Zhang, Y., Nguyen, H. T., Oka, S., Gatanaga, H., & Takiguchi, M. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag105
Intracellular Trafficking of MHC-I in Normal and HIV-1 Nef Expressing Cells.
Schaefer, M. R. (2008) · Deep Blue (University of Michigan)
Metadata
- Authors
- Snary, D., Barnstable, C. J., Bodmer, W. F., & Crumpton, M. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Crumpton, M.J.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1977-08
- Volume
- 7
- Issue
- 8
- Pages
- 580-585
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2099618881
- Cited by
- 181
- References
- 27
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 8 · 2012: 6
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- HLA-C, histocompatibility antigens, beta2-microglobulin, antigenic structure, sedimentation, antigen expression
- MeSH terms
- beta 2-Microglobulin, Cell Line, Cell Membrane, Chemistry, Glycoproteins, Histocompatibility Antigens, HLA Antigens, Humans, Lymphocytes, Molecular Conformation, Molecular Weight, Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.